ACAD (ACADIA Corp) Forvard P/S multiplikatori
Daybue savdolari va barqaror nevrologik portfel kuchli pul oqimini ta'minlaydi, bu esa ACADIA Pharmaceuticals (ACAD) kompaniyasining forward P/S grafigi dinamikasini harakatga keltiradi. 5.30 qiymati joriy baholash holatini ko'rsatadi. Noyob patologiyalar bozoridagi mutlaq narx belgilash kuchi barqarorlikni kafolatlaydi, Parkinson kasalligi davolash vositalarining ishlab chiqilishi esa risklarni minimallashtirib, yangi ilmiy tadqiqotlar uchun resurslar taqdim etadi.
ACADIA Corp (ACAD) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- biznesning bozor baholash ko'rsatkichlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati ACADIA Pharmaceuticals|ACAD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ACADIA Pharmaceuticals|ACAD - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar ACADIA Corp|ACAD - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari ACADIA Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi acadia-pharm.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
ACAD - Sof foyda|Kelajakdagi foyda ACADIA Pharmaceuticals|ACAD - Bozor narxining sof foydaga nisbati|Forvard P/E multiplikatori ACADIA Pharmaceuticals Inc|ACAD - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|EV/EBITDA multiplikatori ACADIA Corp|ACAD - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) ACADIA Pharmaceuticals|ACAD - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi acadia-pharm.com|ACAD - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi ACADIA Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:ACADIA Pharmaceuticals Inc. ACAD
ACADIA Pharmaceuticals (ACAD) kompaniyasining fundamental qiymatini bozor spekulyatsiyalaridan ajratish uchun, joriy bozor kapitalizatsiyasini prognoz qilingan savdo hajmlari bilan solishtiruvchi kutilayotgan narx-savdo koeffitsiyentini baholash muhimdir. Ushbu koeffitsiyentning barqarorligi shartnomaviy model va hab avtomatizatsiyasi tufayli ishlab chiqarishning to'xtab qolmasligi bilan ta'minlanadi, bu esa ko'p karra inflyatsiya xavfini minimallashtiradi va biznesning operatsion zarbalarga chidamliligini tasdiqlaydi.
ACADIA Pharmaceuticals (ACAD) raqobatchilari
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|NBIX (Neurocrine) - Kelajakdagi narxning daromadga nisbati|Regencell - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Corp)|XENE: Forvard P/S multiplikatori|vikingtherapeutics.com (VKTX) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Supernus|CPRX: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Denali Therapeutics Inc (DNLI)|Forvard narx/daromad multiplikatori Harmony Corp HRMY|Forvard P/S multiplikatori BHVN (Biohaven Ltd.)|Forvard P/S multiplikatori amylyx.com AMLX|Trevi Therapeutics, Inc. - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Forvard narx/daromad multiplikatori|AVXL: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati CeriBell EEG (CBLL)|Forvard narx/daromad multiplikatori PRTA|Forvard P/S multiplikatori Alector Therapeutics|Forvard narx/daromad multiplikatori ANNX (Annexon)|Narxning kutilayotgan daromadga nisbati OMER|Forvard P/S multiplikatori NGNE (Neurogene Corp)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati AC Immune Inc (ACIU)|Voyager Therapeutics - Forvard P/S multiplikatori|neumoratx.com (NMRA) - Forvard narx/daromad multiplikatori|SCLX: Forvard P/S multiplikatori|Tevogen Bio Holdings Inc. (TVGN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Alpha Cognition Inc|Narxning prognoz qilingan daromadga nisbati CGTX|Narxning prognoz qilingan daromadga nisbati Inhibikase Therapeutics (IKT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati cassavasciences.com|Forvard P/S multiplikatori ASRT (Assertio)|Forvard P/S multiplikatori Coya Therapeutics Inc COYA|VistaGen Therapeutics Inc - Forvard P/S multiplikatori|Ovid Therapeutics Inc. (OVID) - Forvard narx/daromad multiplikatori|ABOS: Forvard P/S multiplikatori|cervomed.com (CRVO) - Forvard P/S multiplikatori|ATHE (Alterity Therapeutics Ltd.) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati CLNN (Clene Nanomedicine)|Narxning prognoz qilingan daromadga nisbati PepGen Inc. (PEPG)|Jupiter Neurosciences, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori RLMD (Relmada Therapeutics)|annovisbio.com (ANVS) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|GRCE: Forvard narx/daromad multiplikatori|AIFF - Forvard P/S multiplikatori|anewmeds.com (KLTO) - Narxning prognoz qilingan daromadga nisbati|NeuroSense Therapeutics Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals|Bozor kapitallashuvining kelajakdagi daromadga nisbati MetaVia, Inc. MTVA|Forvard P/S multiplikatori NRXS|Forvard P/S multiplikatori heliusmedical.com (HSDT)|Forvard P/S multiplikatori PASG (Passage Bio)|NEUP - Forvard narx/daromad multiplikatori|Minerva Neurosciences - Forvard P/S multiplikatori|ATHA - Forvard P/S multiplikatori|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|Protagenic (PTIX) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori KTTA|Forvard P/S multiplikatori cortigent.com (CRGT)|Avenue Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx BCLI|CARA - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati CHRO|ELYM: Forvard P/S multiplikatori|Intra-Cellular Therapies, Inc. - Sotuvga nisbatan forvard narx|LBPH (Longboard Pharmaceuticals, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Marinus Pharmaceuticals Inc|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|NRBO (NeuroBo Pharma) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Sage Therapeutics, Inc. SAGE|SNPX - Forvard narx/daromad multiplikatori|Trevena - Forvard P/S multiplikatori|VIGL - Forvard P/S multiplikatori|WENA: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cerevel Corp
